These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7720476)

  • 1. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism.
    Zighelboim J; Talley NJ; Phillips SF; Harmsen WS; Zinsmeister AR
    Dig Dis Sci; 1995 Apr; 40(4):819-27. PubMed ID: 7720476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome.
    Hammer J; Phillips SF; Talley NJ; Camilleri M
    Aliment Pharmacol Ther; 1993 Oct; 7(5):543-51. PubMed ID: 8280823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron).
    Goldberg PA; Kamm MA; Setti-Carraro P; van der Sijp JR; Roth C
    Digestion; 1996; 57(6):478-83. PubMed ID: 8913711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?
    Maxton DG; Morris J; Whorwell PJ
    Aliment Pharmacol Ther; 1996 Aug; 10(4):595-9. PubMed ID: 8853764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.
    Delvaux M; Louvel D; Mamet JP; Campos-Oriola R; Frexinos J
    Aliment Pharmacol Ther; 1998 Sep; 12(9):849-55. PubMed ID: 9768527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
    Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR
    Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome.
    Louvel D; Delvaux M; Felez A; Fioramonti J; Bueno L; Lazorthes Y; Frexinos J
    Gut; 1996 Nov; 39(5):741-7. PubMed ID: 9014776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse.
    Whitehead WE; Crowell MD; Davidoff AL; Palsson OS; Schuster MM
    Dig Dis Sci; 1997 Apr; 42(4):796-804. PubMed ID: 9125652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome.
    Thumshirn M; Coulie B; Camilleri M; Zinsmeister AR; Burton DD; Van Dyke C
    Aliment Pharmacol Ther; 2000 Jul; 14(7):869-78. PubMed ID: 10886042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients.
    Hasler WL; Soudah HC; Owyang C
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1206-11. PubMed ID: 8138933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
    Delvaux M; Beck A; Jacob J; Bouzamondo H; Weber FT; Frexinos J
    Aliment Pharmacol Ther; 2004 Jul; 20(2):237-46. PubMed ID: 15233705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal function and bowel habit in irritable bowel syndrome.
    Distrutti E; Salvioli B; Azpiroz F; Malagelada JR
    Am J Gastroenterol; 2004 Jan; 99(1):131-7. PubMed ID: 14687154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception.
    Whitehead WE; Palsson OS
    Gastroenterology; 1998 Nov; 115(5):1263-71. PubMed ID: 9797383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome.
    Lee KJ; Kim JH; Cho SW
    Aliment Pharmacol Ther; 2005 Nov; 22(10):981-8. PubMed ID: 16268973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects.
    Prior A; Maxton DG; Whorwell PJ
    Gut; 1990 Apr; 31(4):458-62. PubMed ID: 2338274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome.
    Prior A; Colgan SM; Whorwell PJ
    Gut; 1990 Aug; 31(8):896-8. PubMed ID: 2387513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects.
    Cook IJ; van Eeden A; Collins SM
    Gastroenterology; 1987 Oct; 93(4):727-33. PubMed ID: 3623019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT4 receptor antagonism in irritable bowel syndrome: effect of SB-207266-A on rectal sensitivity and small bowel transit.
    Houghton LA; Jackson NA; Whorwell PJ; Cooper SM
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1437-44. PubMed ID: 10571599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception.
    Harraf F; Schmulson M; Saba L; Niazi N; Fass R; Munakata J; Diehl D; Mertz H; Naliboff B; Mayer EA
    Gut; 1998 Sep; 43(3):388-94. PubMed ID: 9863485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of oddi dysfunction, type III.
    Chun A; Desautels S; Slivka A; Mitrani C; Starz T; DiLorenzo C; Wald A
    Dig Dis Sci; 1999 Mar; 44(3):631-6. PubMed ID: 10080161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.